Acta Scientific Biotechnology

Editorial Volume 5 Issue 3

Genetic Polymorphic Associations of Anti-Mullerian Hormone and Luteinizing Hormone/Chorionic Gonadotropin Receptor in Women Suffering from Polycystic Ovarian Syndrome: Insights from South Indian Population

Khadeeja Arshed*

Department of Biotechnology, Russia

*Corresponding Author: Khadeeja Arshed, Department of Biotechnology, Russia.

Received: April 12, 2024; Published: May 01, 2024

Abstract

In the past, only nature could create pathogens. Through evolution, it demonstrated an impressive ability to produce a wide range of infectious agents. But now, thanks to advancements in biotechnology, humans can engineer new viruses and bacteria. Synthetic biology, in particular, offers exciting opportunities to better understand disease-causing agents and create new medical treatments and diagnostic tools. However, these advancements also bring the risk that some of the deadliest pathogens in history could be recreated without needing access to natural sources. Recombineering techniques are widely used in laboratories, but they do have some limitations. Recently, there have been many new genome-editing technologies emerging. One example is CRISPR, which has revolutionized the ability to edit the genetic code.

References

  1. Nelson C. “4.0 (CC BY-NC-ND) Engineered pathogens: the opportunities, risks and challenges” (2019).
  2. Herfst S., et al. “Airborne transmission of influenza A/H5N1 virus between ferrets”. Science6088 (2012): 1534-1541.
  3. Kupferschmidt K. “How Canadian researchers reconstituted an extinct poxvirus for $100,000 using mail-order DNA”. Science (2018).
  4. Bressler RD. “Designer bugs’: how the next pandemic might come from a lab” (2018).
  5. Shinomiya N., et al. “Reconsidering the need for gain-of-function research on enhanced potential pandemic pathogens in the post-COVID-19 era”. Frontiers in Bioengineering and Biotechnology 10 (2022).

Citation

Citation: Khadeeja Arshed. “Dual Nature of Biotechnological Innovation".Acta Scientific Biotechnology 5.3 (2024): 01.

Copyright

Copyright: © 2024 Khadeeja Arshed. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US